FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2326133032> ?p ?o ?g. }

• W2326133032 endingPage "7243" @default.
• W2326133032 startingPage "7234" @default.
• W2326133032 abstract "FGFRs (fibroblast growth factor receptors) are encoded by four genes (FGFR1 – 4). Alternative splicing results in various receptor isoforms. The FGFR2-IIIb variant is present in a wide variety of epithelia, including the bladder epithelium. Recently, we have shown that FGFR2-IIIb is downregulated in a subset of transitional cell carcinomas of the bladder, and that this downregulation is associated with a poor prognosis. We investigated possible tumour suppressive properties of FGFR2-IIIb by transfecting two human bladder tumour cell lines, J82 and T24, which have no endogenous FGFR2-IIIb expression, with FGFR2-IIIb cDNA. No stable clones expressing FGFR2-IIIb were isolated with the J82 cell line. For the T24 cell line, stable transfectants expressing FGFR2-IIIb had reduced growth in vitro and formed fewer tumours in nude mice which, in addition, grew more slowly. The potential mechanisms leading to decreased FGFR2-IIIb mRNA levels were also investigated. The 5′ region of the human FGFR2 gene was isolated and found to contain a CpG island which was partially methylated in more than half the cell lines and tumours which do not express FGFR2-IIIb. No homozygous deletion was identified in any of the tumours or cell lines with reduced levels of FGFR2-IIIb. Mutational analysis of the entire coding region of FGFR2-IIIb at the transcript level was performed in 33 bladder tumours. In addition to normal FGFR2-IIIb mRNA, abnormal transcripts were detected in two tumour samples. These abnormal mRNAs resulted from exon skipping which affected the region encoding the kinase domain. Altogether, these results show that FGFR2-IIIb has tumour growth suppressive properties in bladder carcinomas and suggest possible mechanisms of FGFR2 gene inactivation." @default.
• W2326133032 created "2016-06-24" @default.
• W2326133032 creator A5004037094 @default.
• W2326133032 creator A5004962594 @default.
• W2326133032 creator A5011387243 @default.
• W2326133032 creator A5018091647 @default.
• W2326133032 creator A5037017972 @default.
• W2326133032 creator A5039283945 @default.
• W2326133032 creator A5041413715 @default.
• W2326133032 creator A5042140841 @default.
• W2326133032 creator A5052689016 @default.
• W2326133032 creator A5073381688 @default.
• W2326133032 creator A5080087146 @default.
• W2326133032 creator A5088103291 @default.
• W2326133032 date "1999-12-02" @default.
• W2326133032 modified "2023-10-13" @default.
• W2326133032 title "Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer" @default.
• W2326133032 cites W1598196431 @default.
• W2326133032 cites W1651458958 @default.
• W2326133032 cites W1686153396 @default.
• W2326133032 cites W1787537093 @default.
• W2326133032 cites W1984511708 @default.
• W2326133032 cites W1985737377 @default.
• W2326133032 cites W1987188800 @default.
• W2326133032 cites W1988365075 @default.
• W2326133032 cites W1992401642 @default.
• W2326133032 cites W2003925068 @default.
• W2326133032 cites W2006874202 @default.
• W2326133032 cites W2012191338 @default.
• W2326133032 cites W2012677818 @default.
• W2326133032 cites W2016156871 @default.
• W2326133032 cites W2016396075 @default.
• W2326133032 cites W2017384019 @default.
• W2326133032 cites W2018542248 @default.
• W2326133032 cites W2023658543 @default.
• W2326133032 cites W2028828556 @default.
• W2326133032 cites W2035664221 @default.
• W2326133032 cites W2042202567 @default.
• W2326133032 cites W2047727235 @default.
• W2326133032 cites W2054290966 @default.
• W2326133032 cites W2057409901 @default.
• W2326133032 cites W2057729296 @default.
• W2326133032 cites W2060029591 @default.
• W2326133032 cites W2061445402 @default.
• W2326133032 cites W2072578713 @default.
• W2326133032 cites W2073292917 @default.
• W2326133032 cites W2074919384 @default.
• W2326133032 cites W2085316863 @default.
• W2326133032 cites W2086359733 @default.
• W2326133032 cites W2088775512 @default.
• W2326133032 cites W2134962084 @default.
• W2326133032 cites W2144413423 @default.
• W2326133032 cites W2144833976 @default.
• W2326133032 cites W2160399392 @default.
• W2326133032 cites W2314374552 @default.
• W2326133032 cites W2317853404 @default.
• W2326133032 cites W2321323503 @default.
• W2326133032 cites W2328703921 @default.
• W2326133032 cites W2333824332 @default.
• W2326133032 cites W24211996 @default.
• W2326133032 cites W4255497057 @default.
• W2326133032 cites W4255520976 @default.
• W2326133032 cites W67169912 @default.
• W2326133032 doi "https://doi.org/10.1038/sj.onc.1203186" @default.
• W2326133032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10602477" @default.
• W2326133032 hasPublicationYear "1999" @default.
• W2326133032 type Work @default.
• W2326133032 sameAs 2326133032 @default.
• W2326133032 citedByCount "125" @default.
• W2326133032 countsByYear W23261330322012 @default.
• W2326133032 countsByYear W23261330322013 @default.
• W2326133032 countsByYear W23261330322014 @default.
• W2326133032 countsByYear W23261330322015 @default.
• W2326133032 countsByYear W23261330322016 @default.
• W2326133032 countsByYear W23261330322017 @default.
• W2326133032 countsByYear W23261330322018 @default.
• W2326133032 countsByYear W23261330322019 @default.
• W2326133032 countsByYear W23261330322020 @default.
• W2326133032 countsByYear W23261330322021 @default.
• W2326133032 countsByYear W23261330322022 @default.
• W2326133032 countsByYear W23261330322023 @default.
• W2326133032 crossrefType "journal-article" @default.
• W2326133032 hasAuthorship W2326133032A5004037094 @default.
• W2326133032 hasAuthorship W2326133032A5004962594 @default.
• W2326133032 hasAuthorship W2326133032A5011387243 @default.
• W2326133032 hasAuthorship W2326133032A5018091647 @default.
• W2326133032 hasAuthorship W2326133032A5037017972 @default.
• W2326133032 hasAuthorship W2326133032A5039283945 @default.
• W2326133032 hasAuthorship W2326133032A5041413715 @default.
• W2326133032 hasAuthorship W2326133032A5042140841 @default.
• W2326133032 hasAuthorship W2326133032A5052689016 @default.
• W2326133032 hasAuthorship W2326133032A5073381688 @default.
• W2326133032 hasAuthorship W2326133032A5080087146 @default.
• W2326133032 hasAuthorship W2326133032A5088103291 @default.
• W2326133032 hasBestOaLocation W23261330321 @default.
• W2326133032 hasConcept C104317684 @default.
• W2326133032 hasConcept C121608353 @default.
• W2326133032 hasConcept C153911025 @default.

• next